Performance forecast: in the first three quarters of 2021, the company is expected to achieve a net profit of 20-250 million yuan, compared with a loss of 96.21 million yuan in the same period last year. Liantianmei contributed a net profit of 25.4 million yuan. The company is expected to achieve a net profit of 1.5-200 million yuan in the third quarter, an increase of 54.9% 106.5% over the same period last year. The company completed the equity change of major real estate projects and the collection of major equity payments in the third quarter, and the proceeds from the sale were confirmed in September.
Acquire the target of high-quality medical and beauty services to speed up the integration of medical and beauty resources. On October 18, the company announced that it planned to buy a combined 100% stake in Aurora held by former Hai Hongxing and Olympic Garden Health for 30 million yuan. Aurora, the target company, was established in 2018. It has two subordinate medical clinics, mainly engaged in medical beauty business, and has three cosmetic dermatologists to provide services such as surgical beauty, skin beauty, dental beauty, traditional Chinese medicine beauty and so on. The target customer group covers 18-55-year-old beauty women with high consumption level, with a broader market space and a rich customer base. Aurora achieved an income of 25.75 million yuan and a net profit of 2.214 million yuan in 2020, and 12.634 million yuan and a net profit of 275000 yuan from January to August in 2021. This acquisition of Aurora shares will help the company to further speed up the layout of the medical beauty industry, integrate the medical beauty industry resources, enrich the company's medical beauty industry ecology, and enhance the company's comprehensive strength in the medical beauty field.
Mr. Lin Bifeng was appointed as vice president and new vitality was injected into the management. On the same day, the company announced that the board of directors agreed to appoint Mr. Lin Bifeng as vice president of the company. Mr. Lin Bifeng has rich management experience in the medical and beauty industry. he has served as the general manager of Yunnan chain of Jiuzhou Hospital, the executive vice president of Pacific (Hong Kong) Hospital Investment Management Co., Ltd., the chief adviser of Wuzhou Hanchen plastic surgery Group, and the president of Mabel Medical and Beauty Group. Mr. Lin Bifeng will use his own industry management experience to add new strength to the development of the company.
Strengthen the empowerment of science and technology and construct the product matrix of optoelectronic medical beauty. September 23, Japan Olympic Park Meigu successfully held hands with the international photovoltaic beauty top brand specialist, and obtained the exclusive general agent of optoelectronic products in Chinese mainland, the first batch of agents Divine Pro extraordinary protein machine, Legend Pro legendary beauty muscle two optoelectronic beauty equipment.
Medical staff is a leading global supplier of medical and cosmetic equipment, whose product quality, after-sales service, technical training and market share all have a leading position in the Chinese market. this joint effort is a new breakthrough for the company to enter the upstream of medical beauty and strengthen optoelectronic medical beauty.
Profit forecast and investment advice. It is estimated that the growth rate of the company's homing net profit from 2021 to 2023 is 264.2%, 45.7% and 45.2%, respectively. Taking into account the opening of the business space in the upstream and downstream of the company, the remarkable effect of group empowerment, and the implementation of the equity incentive plan, the future performance is expected to maintain a high growth rate and maintain a "buy" rating.
Risk hint: the layout of medical and beauty business is not as expected, and the production of green fiber is not as expected.